Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea
· Delayed Price · Currency is KRW 5,280.00
0.00 (0.00%)
At close: Apr 28, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 58.30 billion as of April 28, 2026. Its market cap has increased by 8.13% in one year.
Market Cap
58.30B
Enterprise Value
51.07B
Revenue
22.18B
Ranking
n/a
PE Ratio
20.23
Stock Price
5,280.00
Market Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 58.30B, a decrease of -37.10%. That is a compound annual growth rate of -28.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 58.30B | -20.77% |
| Dec 30, 2025 | 73.57B | 28.56% |
| Dec 30, 2024 | 57.23B | -38.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korea No.14 Special Purpose Acquisition | 58.32B |
| JNB Co., Ltd. | 60.97B |
| NH Special Purpose Acquisition 30 Company | 51.32B |
| Laseroptek | 69.18B |
| NH Special Purpose Acquisition 29 Company | 44.99B |
| Bowon Chemical | 75.78B |
| ALT Co., Ltd. | 76.21B |
| Mirae Asset Vision Special Purpose Acquisition 2 Company | 42.92B |